Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

By M. Protani, Michael Coory, Jennifer H Martin. Breast Cancer Research and Treatment, 2010

934 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “A growing number of patients beginning their anticancer treatment are already overweight or obese,188 and additional weight gain is a frequent complication of anticancer treatments.189 Increasing evidence indicates that being overweight increases the risk of recurrence and reduces the likelihood of ”
Nutrition and physical activity guidelines for cancer survivors (2012, background): “Increasing evidence indicates that being overweight increases the risk of recurrence and reduces the likelihood of disease-free and overall survival among those diagnosed with cancer.(53,54,63,76-89) Such data suggest that the avoidance of weight gain and weight maintenance throughout treatment may ”
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review (2021, background): “Thus, poorer clinical outcomes are primarily observed in females with BMI ≥ 25 kg/m2 [96].”
Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies (2014, background): “A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”